CN102549160B - 改善的人长五聚环蛋白3表达系统及其用途 - Google Patents
改善的人长五聚环蛋白3表达系统及其用途 Download PDFInfo
- Publication number
- CN102549160B CN102549160B CN201080034030.4A CN201080034030A CN102549160B CN 102549160 B CN102549160 B CN 102549160B CN 201080034030 A CN201080034030 A CN 201080034030A CN 102549160 B CN102549160 B CN 102549160B
- Authority
- CN
- China
- Prior art keywords
- ptx3
- recombinant human
- ptx
- transfection
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Abstract
Description
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09166759.2 | 2009-07-29 | ||
EP09166759 | 2009-07-29 | ||
PCT/EP2010/060469 WO2011012496A1 (en) | 2009-07-29 | 2010-07-20 | Improved human long pentraxin 3 expression system and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102549160A CN102549160A (zh) | 2012-07-04 |
CN102549160B true CN102549160B (zh) | 2014-04-02 |
Family
ID=41120115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080034030.4A Expired - Fee Related CN102549160B (zh) | 2009-07-29 | 2010-07-20 | 改善的人长五聚环蛋白3表达系统及其用途 |
Country Status (23)
Country | Link |
---|---|
US (1) | US8883446B2 (zh) |
EP (1) | EP2459721B1 (zh) |
JP (1) | JP5859963B2 (zh) |
KR (1) | KR101767695B1 (zh) |
CN (1) | CN102549160B (zh) |
AU (1) | AU2010277786B2 (zh) |
BR (1) | BR112012001980A2 (zh) |
CA (1) | CA2769257C (zh) |
CY (1) | CY1116486T1 (zh) |
DK (1) | DK2459721T3 (zh) |
EA (1) | EA023191B1 (zh) |
ES (1) | ES2432242T3 (zh) |
HK (1) | HK1172649A1 (zh) |
HR (1) | HRP20130947T1 (zh) |
IL (1) | IL217696A (zh) |
ME (1) | ME01566B (zh) |
MX (1) | MX2012001109A (zh) |
PL (1) | PL2459721T3 (zh) |
PT (1) | PT2459721E (zh) |
RS (1) | RS53006B (zh) |
SG (1) | SG177756A1 (zh) |
SI (1) | SI2459721T1 (zh) |
WO (1) | WO2011012496A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10253321B2 (en) | 2013-05-01 | 2019-04-09 | Dna2.0, Inc. | Methods, compositions and kits for a one-step DNA cloning system |
US9206433B2 (en) * | 2013-05-01 | 2015-12-08 | Dna Twopointo, Inc. | Methods, compositions and kits for a one-step DNA cloning system |
TWI528969B (zh) * | 2013-06-07 | 2016-04-11 | 國立成功大學 | 胺基酸序列用於製備抑制ptx3治療鼻咽癌之醫藥組合物之用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1298487B1 (it) | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
CA2492008C (en) * | 2002-03-29 | 2012-06-26 | Xoma Technology Ltd. | Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides |
EP1832295A1 (en) * | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
WO2009095403A1 (en) * | 2008-01-29 | 2009-08-06 | Tecnogen S.P.A. | Expression system and uses thereof for the production of human long pentraxin 3 |
-
2010
- 2010-07-20 ME MEP-2013-126A patent/ME01566B/me unknown
- 2010-07-20 DK DK10740573.0T patent/DK2459721T3/da active
- 2010-07-20 CN CN201080034030.4A patent/CN102549160B/zh not_active Expired - Fee Related
- 2010-07-20 WO PCT/EP2010/060469 patent/WO2011012496A1/en active Application Filing
- 2010-07-20 JP JP2012522103A patent/JP5859963B2/ja not_active Expired - Fee Related
- 2010-07-20 US US13/387,784 patent/US8883446B2/en not_active Expired - Fee Related
- 2010-07-20 PT PT107405730T patent/PT2459721E/pt unknown
- 2010-07-20 RS RS20130466A patent/RS53006B/en unknown
- 2010-07-20 AU AU2010277786A patent/AU2010277786B2/en not_active Ceased
- 2010-07-20 KR KR1020127003628A patent/KR101767695B1/ko active IP Right Grant
- 2010-07-20 EA EA201200198A patent/EA023191B1/ru not_active IP Right Cessation
- 2010-07-20 SG SG2012005518A patent/SG177756A1/en unknown
- 2010-07-20 BR BRBR112012001980-5A patent/BR112012001980A2/pt not_active Application Discontinuation
- 2010-07-20 CA CA2769257A patent/CA2769257C/en not_active Expired - Fee Related
- 2010-07-20 ES ES10740573T patent/ES2432242T3/es active Active
- 2010-07-20 PL PL10740573T patent/PL2459721T3/pl unknown
- 2010-07-20 MX MX2012001109A patent/MX2012001109A/es active IP Right Grant
- 2010-07-20 EP EP10740573.0A patent/EP2459721B1/en active Active
- 2010-07-20 SI SI201030362T patent/SI2459721T1/sl unknown
-
2012
- 2012-01-23 IL IL217696A patent/IL217696A/en not_active IP Right Cessation
- 2012-12-27 HK HK12113464.6A patent/HK1172649A1/zh not_active IP Right Cessation
-
2013
- 2013-10-07 HR HRP20130947AT patent/HRP20130947T1/hr unknown
- 2013-10-25 CY CY20131100942T patent/CY1116486T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2459721A1 (en) | 2012-06-06 |
PT2459721E (pt) | 2013-10-31 |
WO2011012496A1 (en) | 2011-02-03 |
RS53006B (en) | 2014-04-30 |
JP5859963B2 (ja) | 2016-02-16 |
MX2012001109A (es) | 2012-03-26 |
CY1116486T1 (el) | 2017-03-15 |
KR20120047259A (ko) | 2012-05-11 |
CA2769257C (en) | 2017-12-05 |
DK2459721T3 (da) | 2013-11-04 |
PL2459721T3 (pl) | 2014-01-31 |
CN102549160A (zh) | 2012-07-04 |
HRP20130947T1 (hr) | 2013-11-08 |
EP2459721B1 (en) | 2013-09-18 |
US8883446B2 (en) | 2014-11-11 |
EA201200198A1 (ru) | 2012-06-29 |
BR112012001980A2 (pt) | 2015-09-01 |
CA2769257A1 (en) | 2011-02-03 |
SG177756A1 (en) | 2012-02-28 |
EA023191B1 (ru) | 2016-05-31 |
AU2010277786A1 (en) | 2012-03-01 |
SI2459721T1 (sl) | 2013-11-29 |
ME01566B (me) | 2014-09-20 |
HK1172649A1 (zh) | 2013-04-26 |
US20120301873A1 (en) | 2012-11-29 |
JP2013504304A (ja) | 2013-02-07 |
KR101767695B1 (ko) | 2017-08-11 |
IL217696A (en) | 2017-06-29 |
ES2432242T3 (es) | 2013-12-02 |
AU2010277786B2 (en) | 2016-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9334489B2 (en) | CHO expression system | |
Pham et al. | Production and secretion of recombinant thaumatin in tobacco hairy root cultures | |
Shin et al. | N-glycosylation of the SARS-CoV-2 receptor binding domain is important for functional expression in plants | |
CN103328649B (zh) | 用于改善重组酶及其它蛋白的蛋白表达和分泌的新的信号序列 | |
US7741539B2 (en) | Transformed plant cell expressing five mammalian proteins involved in sialylation and a protein involved in galactosylation | |
CN102549160B (zh) | 改善的人长五聚环蛋白3表达系统及其用途 | |
EA022990B1 (ru) | Способ получения клеточной линии млекопитающего, продуцирующей терапевтический белок | |
Fisicaro et al. | Versatile co‐expression of graft‐protective proteins using 2A‐linked cassettes | |
Drake et al. | N-terminal chimaeras with signal sequences enhance the functional expression and alter the subcellular localization of heterologous membrane-bound inorganic pyrophosphatases in yeast | |
Casales et al. | A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector | |
Aronsson et al. | POR hits the road: import and assembly of a plastid protein | |
KR20030032993A (ko) | 다수의 통합 벡터를 함유하는 숙주 세포 | |
Song et al. | The response regulator Slr1588 regulates spsA but is not crucial for salt acclimation of Synechocystis sp. PCC 6803 | |
KR20200035270A (ko) | 안정한 생산자 세포주의 생성을 위한 선택 마커로서 성장 인자 수용체의 구성적으로 활성인 변이체의 용도 | |
Wawro et al. | The perplexities of the ZC3H12A self-mRNA regulation | |
Maleki et al. | High expression of methylotrophic yeast-derived recombinant human erythropoietin in a pH-controlled batch system | |
Dhamne et al. | Lentiviral vector platform for improved erythropoietin expression concomitant with shRNA mediated host cell elastase down regulation | |
Kabiri et al. | Trypanosoma brucei transferrin receptor: functional replacement of the GPI anchor with a transmembrane domain | |
US9850498B2 (en) | Expression cassette | |
Nakatani et al. | Identification of a second catalytically active trans-sialidase in Trypanosoma brucei | |
Kiefer et al. | Production and secretion of functional full-length SARS-CoV-2 spike protein in Chlamydomonas reinhardtii | |
KR101993938B1 (ko) | IFNα2로부터의 SAR 인자를 갖는 발현 시스템 | |
CA2908538A1 (en) | Recombinant production of hiv-1 envelope glycoproteins | |
WO2019133092A1 (en) | Host cells with enhanced protein expression efficiency and uses thereof | |
US8338134B2 (en) | Expression of polypeptides from the nuclear genome of Ostreococcus sp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Free format text: FORMER OWNER: TECNOGEN S. P. A. Effective date: 20130308 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130308 Address after: Rome Italy Applicant after: Sigma-Tau Industrie Farmaceutiche Riunite S. P. A. Address before: Italy Caserta Applicant before: Tecnogen S. P. A. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1172649 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20190720 |